Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00002122 | A Randomized Study of Daily and Intermittent Prophylactic Regimens for the Prevention of Disseminated Mycobacterium Avium Complex (MAC) and Fungal Infections in HIV-Infected Patients | PHASE3 | COMPLETED | 720 | — | — | - | - | Jun 24, 2005 | 12 | United States |
| Name | Type | Description |
|---|---|---|
| Azithromycin | DRUG | - |
| Rifabutin | DRUG | - |
| Fluconazole | DRUG | - |
Inclusion Criteria Concurrent Medication: Allowed: * Preventive therapy with isoniazid for M. tuberculosis. * Maintenance therapy for CMV retinitis. Patients must have: * HIV infection or history of an AIDS-defining condition by CDC criteria. * One documented CD4 count \< 100 cells/mm3 within 1...